| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8235115 | International Journal of Radiation Oncology*Biology*Physics | 2009 | 6 Pages |
Abstract
Our preliminary results showed that the Hypo regimen is feasible and does not reduce biochemical control compared with standard fractionation. The incidence of late complications was not increased when the tumor normalized total doses at 2Gy/fraction was increased from 77.1 to 83.7 Gy in patients treated with either 3 or 3.15 Gy/fraction in the Hypo group, respectively.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Felix M.D., Jack D.Sc., Ph.D., F.R.C.R., F.A.C.R.O.,